eFFECTOR Therapeutics Stock

eFFECTOR Therapeutics ROA

The Return on Assets (ROA) of eFFECTOR Therapeutics (EFTR) as of Aug 17, 2026 is -174.31 %. In the previous year, Return on Assets (ROA) was -77.95 % — a change of 123.63% (lower).

ROA

-174.31 %

YoY

123.63%

Last updated:

In 2026, eFFECTOR Therapeutics's return on assets (ROA) was -174.31 %, a 123.63% increase from the -77.95 % ROA in the previous year.

Access this data via the Eulerpool API
Get Free API Key

eFFECTOR Therapeutics Stock analysis

What does eFFECTOR Therapeutics do? eFFECTOR Therapeutics is one of the most popular companies on Eulerpool.

ROA Details

Understanding eFFECTOR Therapeutics's Return on Assets (ROA)

eFFECTOR Therapeutics's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing eFFECTOR Therapeutics's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider eFFECTOR Therapeutics's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in eFFECTOR Therapeutics’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about eFFECTOR Therapeutics stock

Return on Assets (ROA) of eFFECTOR Therapeutics is -174.31 % in 2026.

Return on Assets (ROA) of eFFECTOR Therapeutics changed from -77.95 % to -174.31 %, representing a 123.63% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Return on Assets (ROA) eFFECTOR Therapeutics since 2006 – with annual values, charts, and detailed analysis.

Return on Assets, also known as ROA, is a financial metric used to measure a company's profitability. It is used to determine how effectively a company uses its assets to generate profits. It is also referred to as the ratio of net income to total assets. ROA is an important indicator of a company's overall financial performance as it measures the company's ability to generate more profit from the assets it employs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Assets (ROA)'s eFFECTOR Therapeutics with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Assets (ROA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Assets (ROA).

Access this data via the Eulerpool API
Get Free API Key

Profitability — eFFECTOR Therapeutics

ROEROAROCEROICAsset TurnoverInventory TurnoverReceivables TurnoverDays Sales OutstandingDays Inventory OutstandingDays Payable OutstandingCash Conversion CycleCROICGross Profit/AssetsFixed Asset TurnoverEquity TurnoverWorking Capital TurnoverPayables TurnoverCapital IntensityReceivables/RevenueInventory/RevenueEBIT/Assets

All Key Metrics — eFFECTOR Therapeutics